Strong Order Intake and Sales Growth
Order intake grew by 11%, with organic growth at 7.4%. Net sales increased by 11.8%, with 9.2% organic growth, reflecting positive development across most regions and business areas.
Improved Margins
Adjusted gross and EBITDA margins improved significantly due to price increases, higher volumes, positive product mix, and productivity efforts. Adjusted EBITDA reached SEK 2.143 billion with a margin of 19.4%.
Solid Financial Position
Free cash flow increased by over 70% to around SEK 1.7 billion. Net debt was SEK 10.5 billion, with a leverage of 1.6x adjusted EBITDA, indicating a strong financial position.
Paragonix Technologies Acquisition Performance
Paragonix showed net sales growth of about 65% in Q4, contributing approximately SEK 240 million in sales, and supported more transplant cases than all advanced preservation companies combined in 2024.
Dividend Increase
The proposed dividend is SEK 4.60 per share, representing 38% of the free cash flow per share.